Impact of Tobacco Cessation on the Development of Bladder Cancer
Vikram Narayan, MD, details the little-known fact that tobacco cessation is a leading preventative strategy of bladder cancer recurrence.
Narayan on Complete Responses, Biomarkers, and Side Effects of Nadofaragene Treatment for NMIBC
Vikram Narayan, MD, expanded on his data regarding nadofaragene and NMIBC published at this year’s SUO Meeting.
Vikram Narayan, MD, Discusses Nadofaragene, Anti-Adenovirus Antibodies and Cystectomy for Patients with NMIBC
Narayan expanded on the other studies he contributed to from SUO investigating nadofaragene for patients with NMIBC.
Vikram M. Narayan, MD, on Nadofaragene Firadenovec Efficacy Across Different Patient Subgroups for NMIBC
At the 2020 SUO Meeting, Vikram M. Narayan, MD, spoke about the preliminary finds of his work with nadofaragene firadenovec.
Vikram Narayan, MD, on the Future of Nadofaragene Firadenovec and Bladder Cancer
Narayan discusses what he thinks the future of nadofaragene firadenovec and bladder cancer are at this year’s SUO Meeting.
2 Clarke Drive Cranbury, NJ 08512